Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Spruce Biosciences, Inc. (SPRB) had Stock-Based Compensation of $0.54M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-14.04M |
|
-- |
|
-- |
|
$14.49M |
|
$-14.49M |
|
$0.45M |
|
$-14.04M |
|
$-14.04M |
|
$-14.04M |
|
$-14.04M |
|
$-14.04M |
|
$-14.04M |
|
$-14.49M |
|
$-14.49M |
|
43.95M |
|
43.95M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$30.58M |
|
-- |
|
$1.07M |
|
$31.65M |
|
$15.67M |
|
-- |
|
$0.66M |
|
$16.32M |
|
$15.32M |
|
$15.32M |
|
$15.32M |
|
42.23M |
|
| Cash Flow Statement Financials | |
$-12.73M |
|
-- |
|
$-0.41M |
|
$38.79M |
|
$25.65M |
|
$-13.14M |
|
|
Stock-Based Compensation |
$0.54M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.95 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.63% |
|
-91.63% |
|
-44.36% |
|
-91.63% |
|
$0.36 |
|
$-0.29 |
|
$-0.29 |
|